Long COVID Trial, Recruiting NCT07051954 Sponsor: Hacettepe University Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT07051954
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Post-COVID-19 Syndrome (also called Long COVID).
  • You are able to read and understand the study information and procedures.
  • You are between 18 and 65 years old.
  • You are willing to take part in the study voluntarily.
  • Your ability to carry out daily activities is moderately affected by Post-COVID-19 — not completely normal, but you are not fully dependent on others either (confirm with trial site regarding the specific scale used).
  • Any ongoing health conditions you have, such as high blood pressure or diabetes, are well managed and under control.
  • You do not have any joint, bone, or nervous system problems that would stop you from being tested on muscle strength, balance, or physical fitness.

Who may not be able to join:

  • You have recently had a heart attack or a blood clot in your lungs.
  • You have a chronic (long-term) health condition that is not well controlled.
  • You have any joint, bone, or movement problems that affect your ability to move around freely.
  • You have a brain or nervous system condition (such as a history of stroke) or a mental health condition that would make it difficult for you to follow instructions or safely complete exercise tests.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: EBRU CALIK, Professor, Hacettepe University

Phone: +905442850087

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
1 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Respiratory muscle strength; Plank Endurance Test; Sorenson Endurance Test; Side Bridge Endurance Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov